190 likes | 427 Views
Precursor Directed Biosynthesis of Useful Pharmaceutical Intermediates. Dr Steven L Cobb s.l.cobb@durham.ac.uk http:// www.dur.ac.uk/chemistry/cobb.group/. Manipulating natural processes to access complex (useful?) molecules . Dr Steven L Cobb s.l.cobb@durham.ac.uk
E N D
Precursor Directed Biosynthesis of Useful Pharmaceutical Intermediates Dr Steven L Cobb s.l.cobb@durham.ac.uk http://www.dur.ac.uk/chemistry/cobb.group/
Manipulating natural processes to access complex (useful?) molecules Dr Steven L Cobb s.l.cobb@durham.ac.uk http://www.dur.ac.uk/chemistry/cobb.group/
Overview Part 1: Natural products: Diversity and Drug discovery Part 2: Combining chemistry and then biology – new compound libraries Part 3: Combining biology and then chemistry – new compound libraries Part 4: 19F NMR as a tool to identify new (biosynthetic) pathways and novel enzymes Novel chemistry Biocatalysts New natural products Building blocks Novel chemistry Biocatalysts Compound libraries (small molecules) Compound libraries (complex molecules)
Part 1: Natural products: Diversity and Drug discovery “Drug Discovery and Natural Products: End of an Era or an Endless Frontier?” Vederas and Li, Science, 2009, 325, 169
Part 1: Natural products: Diversity and Drug discovery Ziconotide (Prialt), a peptide toxin from cone snails approved in 2004 for treatment of chronic pain resulting from spinal cord injury. The cytotoxic trabectedin (Yondelis) isapproved in Europe for the treatment of advanced soft-tissue sarcoma Vederas and Li, Science, 2009, 325, 169
Part 1: Using nature to access complexity Combinatorial biosynthesis Analogsproduced by modification of biosynthetic genes.
Part 2: Combining chemistry and then biology – new compound libraries Precursor-directed biosynthesis of fluorinated iturin A in Bacillus spp. Stephen Moran , Dilip K. Rai , Benjamin R. Clark and Cormac D. Murphy Org. Biomol. Chem., 2009, 7, 644-646
Part 2: Combining chemistry and then biology – new compound libraries • New pacidamycin antibiotics through precursor-directed biosynthesis • S. Grüschow, E. J. Rackham, B. Elkins, P. L. A. Newill, L. Hill, and R. J. M. Goss • ChemBioChem., 2009, 10, 355-360
Part 2: Combining chemistry and then biology – new compound libraries Current work Joint PhD student with Comrac Murphy (UCD)
Part 3: Combining biology and then chemistry – new compound libraries . Gene expression enabling synthetic diversification of unnatural products:chemogeneticgeneration pacidamycinanalogs A. Deb Roy, S. Grüschow, N. Cairns, R. J. M. GossJ. Am. Chem. Soc., 2010, 134, 1224-12245. Needed in this area: new/ improved reactions in aqueous chemistry
Part 3: Combining biology and then chemistry – new compound libraries Current work with Comrac Murphy (UCD)
Part 4: 19F NMR as a tool to identify new pathways and novel enzymes Prof. David O’Hagan S. Cobb PhD Thesis – St. Andrews University 2005
Part 4: 19F NMR as a tool to identify new pathways and novel enzymes Cobb, O'Hagan et al. Chem. Commun., 2004, 592-593
19F NMR as a tool to identify new pathways and novel enzymes
Part 4: 19F NMR as a tool to identify new pathways and novel enzymes The process …. Feed fluorine containing compound into bacteria (cell free extracts) Incubate Run 19F NMR analysis Any new 19F NMR peaks ? – if so identify and purify metabolites produced Purify enzyme or enzymes responsible - new biocatalysts
Part 4: 19F NMR as a tool to identify new pathways and novel enzymes Fluorinated drug metabolism (Murphy and Sandford) Leverhulme Trust (with Cormac Murphy) Prof. Graham Sandford, Durham University (Brock Fine Chemicals Ltd)
Manipulating natural processes to access complex (useful?) molecules Dr Steven L Cobb s.l.cobb@durham.ac.uk http://www.dur.ac.uk/chemistry/cobb.group/
Part 3: Combining biology and then chemistry – new compound libraries Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering Andreas Kirschning , Florian Taft and Tobias KnoblochOrg. Biomol. Chem., 2007, 5, 3245-3259